Imagine feeling out of breath just walking down a hallway, or struggling to tie your shoes because even basic tasks leave you exhausted. For people living with tricuspid regurgitation (TR)—a condition caused by a leaky heart valve—this is a daily reality. TR impacts more than 1.6 million people in the U.S., and until recently, the only option for relief was risky open-heart surgery. But not anymore.
Enter Abbott’s TriClip™ device—a game-changer for people like Gregory, a Vietnam veteran who can now enjoy his passions of tai chi, golf, and traveling again. The TriClip™ is a first-of-its-kind, FDA-approved minimally invasive treatment that repairs the leaky heart valve without the need for major surgery. Delivered through a vein in the leg, the procedure often requires just a single day in the hospital.
This innovative approach means a new lease on life for countless people who were previously told surgery wasn’t an option. With TriClip™, they can breathe easier—literally—and get back to living the life they love.
Also on Coast to Coast
-
Big Anniversaries, Big Savings: Catalina Island Celebrates in Style
-
Sundance 2026 Celebrates Its Legacy with Iconic Screenings, Star Power, and a Nationwide Online Experience
-
Hollywood Hits the Desert: Coast to Coast TV’s Heather Dawson Brings You Inside the Palm Springs Film Awards
-
Hollywood Buzz: Breakups, Honors & Country Queens — This Week’s Must-See Celebrity Scoop!
-
Sunshine, Stars & Southern Flavor: Coast to Coast TV Episode 104